Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723488 · ClinicalTrials.gov registry record · Early Phase 1
A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
A Early Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT01723488: Clinical Trial Early Phase 1 study, sponsored by Avid Radiopharmaceuticals.
NCT01723488 is a Early Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 12 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01723488, a Early Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
\[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.
Primary Outcome
To monitor and assess the safety of IV administration of \[F-18\]T808 To evaluate the bio-distribution and radiation dosimetry of \[F-18\]T808 in participants with low probability of Alzheimer"s disease (AD) using PET/CT whole body imaging To evaluate the metabolism of \[F-18\]T808 in participants with low probability of AD using serial blood samples collected pre- and post-IP administration To evaluate \[F-18\]T808 uptake and signal/background information in brain PET/CT imaging of participants
Interventions
- RADIATION [F18] T808
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Why NCT01723488 stopped before completion
NCT01723488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which [F18] T808 is the first listed.
NCT01723488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01723488 about?
NCT01723488 is a clinical study titled "A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808". \[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.
What is the current status of trial NCT01723488?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01723488?
The interventions under investigation include: [F18] T808 (RADIATION).
Who is sponsoring clinical trial NCT01723488?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01723488's enrollment target sits among peer trials
12 1529th of 2000 higher than 401 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia